pretickt

STERIS plc (STE)

Healthcare · end-of-day data as of Oct 16, 2026

STERIS plc
STE · $21.71B
$222.66+4.3%last 60 sessions · close Oct 16, 2026
$198.79$266.3752 weeks
Buy · 9 analystsPT $276.53 +24.2%
  • P/E vs own-12.6%
  • P/E vs sector-3.3%
  • Target upside+24.2%
  • Off 52w high-16.4%
  • Insiders-$957K
  • FCF yield+4.3%
  • Earnings in19d
  • Trendsideways
  • Sector▲ +16.0%
  • RSI62
  • MA20×50↑ in ~12d
  • Volume1.0x
  • Support-1.7%
  • Resistance+3.2%

The average 12-month analyst price target for STE is $276.53, 24.2% above the last close of $222.66 on Oct 16, 2026; targets range from $267.71 to $289.15. Rating consensus: Buy.

Snapshot

  • P/E27.2x
  • P/E vs sector-3.3%
  • P/E vs own-12.6%
  • Target upside+24.2%
  • ConsensusBuy
  • Market cap$21.71B
  • FCF yield+4.3%
  • Insiders-$957K
  • Earnings in19d
  • News

Why it moved

STERIS plc (STE) fell 0.7% on Oct 16, 2026.

The market (SPY) fell 1.1%; Healthcare stocks fell 0.7%. Most of the move came from the market as a whole.

Market (SPY)-1.1%
Healthcare sector+0.4%
STE specific0.0%

1 story on the day (30-day average 1.9).

Market = SPY. Sector = equal-weight average of the tracked companies in the same sector, net of the market.

Price and events

⇔⇕$203$223$242$262Oct 25Jan 26Apr 26Jul 26Oct 26EDEDEDEDE

Last close $222.66 · -6.3% over 1y · E earnings · D dividend · S split · A analyst rating change

Technicals

  • Trendsideways
  • Sector▲ +16.0%
  • MAs20▲ 50▲ 100▲ 200▼
  • Above MAs3 of 4 above
  • MA20×50↑ in ~12d
  • RSI62
  • Support-1.7%
  • Resistance+3.2%
  • Off 52w high-16.4%
  • Off ATH-16.4%
  • 52w range$222.66
  • Bollingerabove upper
  • MACD2.11
  • ATR+2.2%
  • Volume1.0x

Analyst price targets

Low$267.71
Average$276.53
Median$272.73
High$289.15
Upside+24.2%

3 firms with a target in the last 12 months · last close $222.66 · as of Oct 16, 2026

⇔⇕$194$219$244$269$294Oct 25Feb 26Jun 26Oct 26Feb 27Jun 27+21%+30%
— actual price● bullish target● bearish targethover a dot to see the analysts behind it · wheel or drag to move through time · drag the price axis on the right to stretch it · double-click resets

Strong buy 3 · Buy 4 · Hold 2 · Sell 0 · Strong sell 0

Revenue and free cash flow

Q1 FY2027: Revenue +7.3% year over year, free cash flow 18.7% of revenue, operating margin 19.1%.

RevenueFree cash flow
Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026Q1 FY2027
Q1 FY2027Jun 30, 2026$1.49B2.04$280M45.8%19.1%13.4%
Q4 FY2026Mar 31, 2026$1.59B2.24$245M43.9%19.9%13.9%
Q3 FY2026Dec 31, 2025$1.5B1.96$200M43.8%18.1%12.9%
Q2 FY2026Sep 30, 2025$1.46B1.94$201M44.2%18.4%13.1%
Q1 FY2026Jun 30, 2025$1.39B1.79$326M45.1%17.7%12.8%
Q4 FY2025Mar 31, 2025$1.48B1.48$190M43.3%14.6%9.8%
Q3 FY2025Dec 31, 2024$1.37B1.75$244M44.5%17.9%12.7%
Q2 FY2025Sep 30, 2024$1.33B1.51$149M43.6%16.5%11.3%

Peers

20D
1WSTWest Pharmaceutical Services, Inc.$384.02+0.3%0.0%+1.9%49.1$27.03B
2DGXQuest Diagnostics Incorporated$235.00-1.7%-4.7%-0.5%24.9$25.94B
3LHLabcorp Holdings Inc.$317.95-2.2%-6.1%+5.8%26.3$25.79B
4INCYIncyte Corporation$113.07-0.2%-13.0%+13.6%14.4$22.92B
5STESTERIS plc$222.66-0.7%-16.4%+24.2%27.2$21.71B
6VTRSViatris Inc.$18.66+2.4%0.0%+9.8%—$21.43B
7ZBHZimmer Biomet Holdings, Inc.$94.98+0.6%-7.7%+9.0%23.1$18.12B
8RVTYRevvity, Inc.$152.64-1.3%-3.0%-18.2%72.7$17.03B

Data as of Oct 16, 2026 close.

Latest news

Sentiment classified by AI from the headline (green positive, red negative). Links open the publisher.